AcasăEurope NewsBVB, EBRD to review Romanian market corporate governance code

BVB, EBRD to review Romanian market corporate governance code

Published on

The Bucharest Stock Exchange (BVB) and European Bank for Reconstruction and Development (EBRD) will work together to review the Romanian market’s corporate governance code, aligning it with recent regulatory changes and updated global standards.

According to a joint press release issued on Thursday, this joint initiative is designed to help listed companies improve their governance and reporting quality, by aligning with EU regulatory changes affecting governance structures, the latest G20/OECD Corporate Governance Principles and best practice in the field.

„The updated code is expected to provide guidance on emerging issues in governance and reflect the evolving priorities of stakeholders and enhancing their corporate resilience in a rapidly changing world,” reads the statement.

The revised version of the Code is meant to be released by the end of 2024, so the first year of reporting compliance with the new Code is 2026 for the financial year 2025. The process of reviewing the Code will take into account the input and insights of all market participants.

AGERPRES

Latest articles

Euro trades at 4.9765 RON

The exchange rate of the national leu currency resulting from the quotations announced on...

Antibiotice Iasi reports net profit of 87.9 million RON, up 15 pct, in first nine months

Romanian drug manufacturer Antibiotice Iasi recorded a net profit of 87.9 million RON in...

Fondul Proprietatea, profit of 209.6 million RON in the first nine months

Fondul Proprietatea ended the first nine months of this year with a net profit...

Bucharest Stock Exchange opens Friday’s session in the red on most indices

The Bucharest Stock Exchange (BVB) opened with declines on most indices on Friday, and...

More like this

Euro trades at 4.9765 RON

The exchange rate of the national leu currency resulting from the quotations announced on...

Antibiotice Iasi reports net profit of 87.9 million RON, up 15 pct, in first nine months

Romanian drug manufacturer Antibiotice Iasi recorded a net profit of 87.9 million RON in...

Fondul Proprietatea, profit of 209.6 million RON in the first nine months

Fondul Proprietatea ended the first nine months of this year with a net profit...